#151763

C125PM Colorectal Cell Line

Cat. #151763

C125PM Colorectal Cell Line

Cat. #: 151763

Unit size: 1x10^6 cells / vial

Organism: Human

Tissue: Colon

Disease: Cancer

Model: Tumour line

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Walter Bodmer

Institute: Cancer Research UK, London Research Institute: Lincoln's Inn Fields

Tool Details
Handling
References
Documentation

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: C125PM Colorectal Cell Line
  • Alternate name: C125PM; C125
  • Cancer type: Colorectal cancer
  • Cancers detailed: Adenocarcinoma
  • Research fields: Cancer;Drug development
  • Organism: Human
  • Tissue: Colon
  • Disease: Cancer
  • Growth properties: Adherent
  • Model: Tumour line
  • Conditional: Yes
  • Description: C125PM is a human colorectal adenocarcinoma cell line.
  • Cellosaurus id: CVCL_8175

Handling

  • Format: Frozen
  • Growth medium: Iscove's Modified Dulbecco's Medium, + 10% Foetal Bovine Serum (FBS) + 2 mM Glutamine.
  • Unit size: 1x10^6 cells / vial
  • Shipping conditions: Dry ice
  • Subculture routine: Split sub-confluent cultures (70-80%) 1:3 to 1:6 i.e. seeding at 2-4x10,000 cells/cm² using 0.05% trypsin or trypsin/EDTA; 5% CO₂; 37°C. C125PM cells grow slowly (see growth curve); following resuscitation or subculture the cells take at least 48 hours to re-attach. Cells should be left without disturbance during this time to facilitate adhesion. Centrifugation of the cells (100g x 5 min) at resuscitation to remove DMSO improves the establishment of a viable culture. Once attached, the cells grow in discrete islands and use of trypsin or trypsin/EDTA to subculture the cells (even without knocking the flask) yields large clumps. Further disaggregation may be achieved by repeatedly pipetting the cells.

References

  • Mariella et al. 2024. Mol Oncol. 18(6):1460-1485. PMID: 38468448.
  • Frejno et al. 2017. Mol Syst Biol. 13(11):951. PMID: 29101300.
  • Medico et al. 2015. Nat Commun. 30:7002. PMID: 25926053.
  • Mouradov et al. 2014. Cancer Res. 74(12):3238-3247. PMID: 24755471.
  • Schlicker et al. 2012. BMC Med Genomics. 5:66. PMID: 23272949.
  • Janakiraman et al. 2010. Cancer Res. 70(14):5901-5911. PMID: 20570890.
  • Emaduddin et al. 2008. Proc Natl Acad Sci U S A. 105(7):2358-2362. PMID: 18258742.
  • Liu et al. 2006. Proc Natl Acad Sci U S A. 103(4):976-981. PMID: 16418264.
  • Rowan et al. 2000. Proc Natl Acad Sci U S A. 97(7):3352-3357. PMID: 10737795.

Documentation

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.